Olokizumab superior to placebo and noninferior to adalimumab in RA patients Dr. Shravani Dali22 Sep 2022 3:00 PM GMTIn patients with rheumatoid arthritis who were receiving maintenance methotrexate, olokizumab was superior to placebo and noninferior to adalimumab...
Olokizumab Outperforms Placebo in RA patients on maintenance Methotrexate: NEJM Dr. Kamal Kant Kohli29 Aug 2022 2:30 AM GMTVIENNA: Patients with rheumatoid arthritis taking maintenance methotrexate respond better to olokizumab than to a placebo and non-inferior to...
Graded sensorimotor retraining intervention may help relieve chronic backache: JAMA Dr. Kamal Kant Kohli5 Aug 2022 2:00 PM GMTPeople challenged with chronic back pain have been given hope with a new treatment that focuses on retraining how the back and the brain communicate,...
Zuranolone found effective for postpartum depression in phase 3 study Dr. Kamal Kant Kohli6 Jun 2022 3:45 AM GMTCAMBRIDGE, Mass: Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that the Phase 3 SKYLARK Study of zuranolone,...
Trial that finds Vitamin D does not prevent type 2 diabetes in high risk adults Dr B.P. RAHUL27 May 2022 12:45 PM GMTThe results of the trial showed that supplements had no clinically meaningful effect in high-risk adults, but suggest there may be a benefit for...
Aprocitentan found efficacious in patients with resistant hypertension in Phase 3 study Dr. Kamal Kant Kohli26 May 2022 2:15 PM GMTAprocitentan is an investigational, oral, dual endothelin receptor antagonist designed to potently inhibit the binding of endothelin-1 (ET-1) to ETA...
All doses of Vortioxetine may prevent relapse in patients with major depressive disorder Dr. Shravani Dali5 April 2022 3:30 AM GMTAll doses of vortioxetine are effective for relapse prevention, in patients with remitted major depressive disorder, according to a recent study...
Use of adjunct intra-arterial alteplase beneficial in Patients with Acute Ischemic Stroke Dr. Shravani Dali23 March 2022 3:30 AM GMTAmong patients with large vessel occlusion acute ischemic stroke and successful reperfusion following thrombectomy, the use of adjunct ...
Risankizumab treatment may not benefit severe asthma patients finds NEJM study Dr. Shravani Dali8 Nov 2021 3:30 AM GMTPlacebo treatment was found to be superior to treatment with risankizumab with respect to time to first asthma worsening and annualized rate of...
Rivaroxaban & aspirin benefit PAD patients undergoing lower extremity revascularization: study Dr. Shravani Dali29 Oct 2021 4:15 AM GMTPatients with peripheral artery disease (PAD) undergoing lower extremity revascularization (LER) benefit from low-dose rivaroxaban and aspirin ...
Hydrocortisone does not improve risk of death or bronchopulmonary dysplasia in preterm babies: JAMA Dr. Shravani Dali3 Aug 2021 4:30 AM GMTSystemic Hydrocortisone when initiated 7 to 14 days after birth in ventilator-dependent, very preterm infants do not significantly improve the...
Azithromycin no better than placebo for COVID treatment, finds study Medical Dialogues Bureau20 July 2021 3:45 AM GMTLOS ANGELES: The commonly prescribed antibiotic for Covid-19, azithromycin, is no more effective than a placebo in preventing the viral disease among...
